Sequent Scientific Ltd. | Small-cap | Healthcare
₹190.05
0.52%
| Sequent Scientific Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 15.5B
Gross Profit 7.4B 47.67%
Operating Income 924.1M 5.96%
Net Income 322.6M 2.08%
EPS (Diluted) ₹0.85

Balance Sheet Metrics

Total Assets 16.0B
Total Liabilities 8.3B
Shareholders Equity 7.7B
Debt to Equity 1.08

Cash Flow Metrics

Operating Cash Flow 360.5M
Free Cash Flow 442.7M

Revenue & Profitability Trend

Sequent Scientific Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 15.5B 13.7B 14.2B 14.1B 13.5B
Cost of Goods Sold 8.1B 8.1B 9.0B 8.4B 7.4B
Gross Profit 7.4B 5.5B 5.2B 5.7B 6.2B
Operating Expenses 3.0B 2.0B 2.0B 2.2B 2.1B
Operating Income 924.1M 370.2M 2.8M 674.0M 1.8B
Pre-tax Income 443.1M -546.5M -1.4B 529.3M 1.4B
Income Tax 120.5M -250.3M -156.8M 81.7M 321.8M
Net Income 322.6M -296.1M -1.2B 447.6M 1.0B
EPS (Diluted) ₹0.85 -₹1.44 -₹4.88 ₹1.63 ₹3.85

Income Statement Trend

Sequent Scientific Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 8.7B 8.2B 7.9B 7.8B 7.1B
Non-Current Assets 7.3B 7.2B 7.4B 6.7B 6.8B
Total Assets 16.0B 15.4B 15.3B 14.5B 13.9B
Liabilities
Current Liabilities 5.1B 6.3B 5.6B 5.1B 4.6B
Non-Current Liabilities 3.3B 2.0B 2.2B 2.0B 1.6B
Total Liabilities 8.3B 8.3B 7.8B 7.1B 6.2B
Equity
Total Shareholders Equity 7.7B 7.1B 7.5B 7.4B 7.8B

Balance Sheet Composition

Sequent Scientific Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 443.1M -546.5M -1.4B 529.3M 1.5B
Operating Cash Flow 360.5M 88.5M -176.9M -533.9M 951.2M
Investing Activities
Capital Expenditures -293.9M -116.6M -745.1M -312.7M -445.7M
Investing Cash Flow -293.9M -64.9M -661.9M -959.9M -1.3B
Financing Activities
Dividends Paid - - - -123.4M -
Financing Cash Flow 48.5M 548.1M 776.7M 900.2M -1.1B
Free Cash Flow 442.7M -2.1M -693.7M -18.7M 619.2M

Cash Flow Trend

Sequent Scientific Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 219.54
Forward P/E 36.52
Price to Book 6.59
Price to Sales 2.97
PEG Ratio 36.52

Profitability Ratios

Profit Margin 1.41%
Operating Margin 7.34%
Return on Equity 4.35%
Return on Assets 3.68%

Financial Health

Current Ratio 1.73
Debt to Equity 62.47
Beta 1.12

Per Share Data

EPS (TTM) ₹0.84
Book Value per Share ₹27.97
Revenue per Share ₹62.40

Financial data is updated regularly. All figures are in the company's reporting currency.